News from elcelyx therapeutics A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 21, 2013, 08:00 ET

Elcelyx Therapeutics Announces Positive Results in Phase 2b Study of NewMet in Type 2 Diabetes

 Elcelyx Therapeutics announced today the completion of a 12-week Phase 2b study of NewMet™, a delayed-release formulation of metformin...

Sep 17, 2013, 08:00 ET

Elcelyx Therapeutics to Present Clinical Data on NewMet in Type 2 Diabetes at the 49th Annual European Association for the Study of Diabetes Meeting

 Elcelyx Therapeutics today announced that clinical advisor, John Buse, M.D., Ph.D., will present clinical data for NewMet™, a...

Sep 04, 2013, 08:00 ET

Elcelyx Therapeutics' NewMet for Type 2 Diabetes Meets Primary Endpoint in Phase 2b Study

 Elcelyx Therapeutics announced today that NewMet™, the delayed-release formulation of generic metformin for the treatment of...

Jun 22, 2013, 11:00 ET

Elcelyx Therapeutics Reports Positive Data for NewMet in Type 2 Diabetes at 2013 American Diabetes Association Scientific Sessions

 Elcelyx Therapeutics announced today that clinical study results confirm that the primary site of action of Type 2 diabetes medicine metformin...

Jun 14, 2013, 17:05 ET

Elcelyx Therapeutics to Present Clinical Data on NewMet™ in Type 2 Diabetes at the 2013 American Diabetes Association Scientific Sessions

 Elcelyx Therapeutics today announced that the company and principal investigator Ralph A. DeFronzo, M.D. will present posters related to...

May 20, 2013, 08:00 ET

Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes

Enrollment of patients with Type 2 diabetes is underway in Elcelyx Therapeutics' Phase 2b dose-finding clinical trial of product candidate...

Feb 14, 2013, 07:30 ET

Elcelyx Therapeutics Completes $20 Million Series C Financing to Advance NewMet and Lovidia

 Elcelyx Therapeutics announced today the closing of a $20 million Series C financing to fund development of product candidates NewMet™...

Aug 13, 2012, 08:00 ET

Elcelyx Therapeutics Names Mark Wiggins Senior Vice President of Business Development, Ginger Graham to Board of Directors

Elcelyx Therapeutics announced today that Mark Wiggins has joined the company as Senior Vice President of Business Development and Ginger Graham...

Aug 13, 2012, 08:00 ET

Elcelyx Therapeutics Extends Series B Financing for Late-Stage Clinical Programs in Weight Loss and Diabetes

Elcelyx Therapeutics announced today that it has secured $4 million of a $7 million extension of its Series B private equity financing. Existing...